Assessing the Value of Avocados on Glycemic Control in Type 2 Diabetes
The Effects of Hass Avocados on Glycemic Control in Persons With Type 2 Diabetes: A Randomized Controlled Crossover Trial
Pennington Biomedical Research Center
48 participants
Oct 10, 2023
INTERVENTIONAL
Conditions
Summary
The objective of this study is to assess the effects of Hass Avocados on glycemic control. The investigators hypothesize that Hass Avocado consumption will reduce fasting blood sugar compared to an isocaloric amount of other fruit during controlled feeding.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The Hass Avocado group will consume 7 avocados a week (1 / day; \~240 kcals/d).
The other fruits group will consume fruit(s) matched to the avocado in energy and form (i.e., solid fruit).
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05958368